AAAAAA

   
Results: 1-15 |
Results: 15
THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY
Authors: HOETELMANS RMW REIJERS MHE WEVERLING GJ TENKATE RW WIT FWNM MULDER JW WEIGEL HM FRISSEN PHJ ROOS M JURRIAANS S SCHUITEMAKER H DEWOLF F BEIJNEN JH LANGE JMA
Citation: Rmw. Hoetelmans et al., THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY, AIDS, 12(11), 1998, pp. 111-115
MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY
Authors: REIJERS MHE WEVERLING GJ JURRIAANS S WIT FWNM WEIGEL HM TENKATE RW MULDER JW FRISSEN PHJ VANLEEUWEN R REISS P SCHUITEMAKER H DEWOLF F LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190
PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS
Authors: BRUISTEN SM FRISSEN PHJ VANSWIETEN P HARRIGAN PR KINGHORN I LARDER B WEIGEL HM DEVRIES E REGEZ RM HENRICHS JH KOOT M HUISMAN JG
Citation: Sm. Bruisten et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS, AIDS research and human retroviruses, 13(4), 1997, pp. 327-335
HIV-RELATED THROMBOTIC THROMBOCYTOPENIC PURPURA - REPORT OF 2 CASES AND A REVIEW OF THE LITERATURE
Authors: DEMAN AME SMULDERS YM ROOZENDAAL KJ FRISSEN PHJ
Citation: Ame. Deman et al., HIV-RELATED THROMBOTIC THROMBOCYTOPENIC PURPURA - REPORT OF 2 CASES AND A REVIEW OF THE LITERATURE, Netherlands journal of medicine, 51(3), 1997, pp. 103-109
COTRIMOXAZOLE IS EFFECTIVE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS - A CASE-CONTROL STUDY
Authors: WEIGEL HM DEVRIES E REGEZ RM HENRICHS JH TENVELDEN JJAM FRISSEN PHJ VANDERMEER JTM
Citation: Hm. Weigel et al., COTRIMOXAZOLE IS EFFECTIVE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS - A CASE-CONTROL STUDY, Scandinavian journal of infectious diseases, 29(5), 1997, pp. 499-502
HIGH-DOSE INTERFERON-ALPHA-2A EXERTS POTENT ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NOT ASSOCIATED WITH ANTITUMOR-ACTIVITY IN SUBJECTS WITH KAPOSIS-SARCOMA
Authors: FRISSEN PHJ DEWOLF F REISS P BAKKER PJM VEENHOF CHN DANNER SA GOUDSMIT J LANGE JMA
Citation: Phj. Frissen et al., HIGH-DOSE INTERFERON-ALPHA-2A EXERTS POTENT ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NOT ASSOCIATED WITH ANTITUMOR-ACTIVITY IN SUBJECTS WITH KAPOSIS-SARCOMA, The Journal of infectious diseases, 176(3), 1997, pp. 811-814
PREDICTIVE VALUE FOR SURVIVAL OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS P55 AND P75 DURING ZIDOVUDINE-CONTAINING TREATMENT IN SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ WEVERLING GJ ENDERT E JANSEN J SAUERWEIN HP LANGE JMA
Citation: Phj. Frissen et al., PREDICTIVE VALUE FOR SURVIVAL OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS P55 AND P75 DURING ZIDOVUDINE-CONTAINING TREATMENT IN SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 482-488
LESSON OF THE WEEK - HYPOVITAMINOSIS-D IN IMMIGRANT WOMEN - SLOW TO BE DIAGNOSED
Authors: NELLEN JFJB SMULDERS YM FRISSEN PHJ SLAATS EH SILBERBUSCH J
Citation: Jfjb. Nellen et al., LESSON OF THE WEEK - HYPOVITAMINOSIS-D IN IMMIGRANT WOMEN - SLOW TO BE DIAGNOSED, BMJ. British medical journal, 312(7030), 1996, pp. 570-572
RENAL TUBULAR-ACIDOSIS - PATHOPHYSIOLOGY AND DIAGNOSIS
Authors: SMULDERS YM FRISSEN PHJ SLAATS EH SILBERBUSCH JP
Citation: Ym. Smulders et al., RENAL TUBULAR-ACIDOSIS - PATHOPHYSIOLOGY AND DIAGNOSIS, Archives of internal medicine, 156(15), 1996, pp. 1629-1636
LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE
Authors: BURGER DM MEENHORST PL TENNAPEL CHH MULDER JW HENRICHS JH FRISSEN PHJ KROON FP KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE, European journal of pharmaceutical sciences, 3(1), 1995, pp. 7-13
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
HERPES-ZOSTER, IMMUNOLOGICAL DETERIORATION AND DISEASE PROGRESSION INHIV-1 INFECTION
Authors: VEENSTRA J KROL A VANPRAAG RME FRISSEN PHJ SCHELLEKENS PTA LANGE JMA COUTINHO RA VANDERMEER JTM
Citation: J. Veenstra et al., HERPES-ZOSTER, IMMUNOLOGICAL DETERIORATION AND DISEASE PROGRESSION INHIV-1 INFECTION, AIDS, 9(10), 1995, pp. 1153-1158
ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ VANDERENDE ME TENNAPEL CHH WEIGEL HM SCHREIJ GS KAUFFMANN RH KOOPMANS PP HOEPELMAN AIM DEBOER JB WEVERLING GJ HAVERKAMP G DOWD P MIEDEMA F SCHUURMAN R BOUCHER CAB LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
LONGITUDINAL-STUDY ON THE QUALITY-OF-LIFE OF SYMPTOMATIC HIV-INFECTEDPATIENTS IN A TRIAL OF ZIDOVUDINE VERSUS ZIDOVUDINE AND INTERFERON-ALPHA
Authors: DEBOER JB VANDAM FSAM SPRANGERS MAG FRISSEN PHJ LANGE JMA
Citation: Jb. Deboer et al., LONGITUDINAL-STUDY ON THE QUALITY-OF-LIFE OF SYMPTOMATIC HIV-INFECTEDPATIENTS IN A TRIAL OF ZIDOVUDINE VERSUS ZIDOVUDINE AND INTERFERON-ALPHA, AIDS, 7(7), 1993, pp. 947-953
THE CONCORDE TRIAL
Authors: DANNER SA SCHATTENKERK JKME LOELIGER AE VANDERMEER JTM REISS P HENRICHS JM FRISSEN PHJ WEIGEL HM MULDER JW MEENHORST PL VANDERWOLF MGB TENVEEN JH CLAESSEN FAP VEENSTRA J BORLEFFS JCC HOEPELMAN IM SCHNEIDER ME DEMARIE S VANDERENDE ME VOETS W KAUFFMANN RH KROON FP JUTTMAN JR FOLMER SCCR FERWERDA J TENKATE RW VANLEUSEN R VREDEN SGS PERENBOOM R SPRENGER HG TENNAPEL CHH
Citation: Sa. Danner et al., THE CONCORDE TRIAL, Lancet, 341(8855), 1993, pp. 1276-1276
Risultati: 1-15 |